GSK has reported much-needed progress with two of its cancer therapies, with a phase 3 trial win for immunotherapy Jemperli in endometrial cancer and the start of a review in the EU for myelofibrosis ...
For Derek Falvey and the Twins, it shouldn’t be about getting the biggest name on the market but rather the best fit. “You can’t separate the business and the baseball side,” Falvey said after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback